Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

The Evaluation of Metal Co-ordinating Bis-Thiosemicarbazones as Potential Anti-malarial Agents.

Akladios FN, Andrew SD, Boog SJ, de Kock C, Haynes RK, Parkinson CJ.

Med Chem. 2019;15(1):51-58. doi: 10.2174/1573406414666180525132204.

PMID:
29804537
2.

Cytotoxic activity of expanded coordination bis-thiosemicarbazones and copper complexes thereof.

Akladios FN, Andrew SD, Parkinson CJ.

J Biol Inorg Chem. 2016 Dec;21(8):931-944. Epub 2016 Sep 19.

PMID:
27645502
3.

Investigation of the cytotoxic implications of metal chelators against melanoma and approaches to improve the cytotoxicity profiles of metal coordinating agents.

Akladios FN, Andrew SD, Parkinson CJ.

Biometals. 2016 Oct;29(5):789-805. doi: 10.1007/s10534-016-9945-1. Epub 2016 Jul 7.

PMID:
27389037
4.
5.

Improved cytotoxicity of pyridyl-substituted thiosemicarbazones against MCF-7 when used as metal ionophores.

Akladios FN, Andrew SD, Parkinson CJ.

Biometals. 2016 Feb;29(1):157-70. doi: 10.1007/s10534-015-9905-1. Epub 2015 Dec 18.

PMID:
26683314
6.

Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis.

Akladios FN, Andrew SD, Parkinson CJ.

Bioorg Med Chem. 2015 Jul 1;23(13):3097-104. doi: 10.1016/j.bmc.2015.05.006. Epub 2015 May 11.

PMID:
26022081
7.

Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women.

Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL.

J Clin Microbiol. 2013 Oct;51(10):3270-6. doi: 10.1128/JCM.01315-13. Epub 2013 Jul 24.

8.

Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers.

Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL.

Pediatr Infect Dis J. 2013 May;32(5):543-8. doi: 10.1097/INF.0b013e31828ba3f1.

PMID:
23429563
9.

Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls.

Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL.

Clin Microbiol Infect. 2013 Apr;19(4):E173-80. doi: 10.1111/1469-0691.12123. Epub 2013 Feb 7.

10.

Multiplex PCR-based reverse line blot assay for simultaneous detection of 22 virulence genes in uropathogenic Escherichia coli.

Kudinha T, Kong F, Johnson JR, Andrew SD, Anderson P, Gilbert GL.

Appl Environ Microbiol. 2012 Feb;78(4):1198-202. doi: 10.1128/AEM.06921-11. Epub 2011 Dec 9.

11.

RET-mediated gene expression pattern is affected by isoform but not oncogenic mutation.

Hickey JG, Myers SM, Tian X, Zhu SJ, V Shaw JL, Andrew SD, Richardson DS, Brettschneider J, Mulligan LM.

Genes Chromosomes Cancer. 2009 May;48(5):429-40. doi: 10.1002/gcc.20653.

PMID:
19226610
12.

A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2.

Vanhorne JB, Andrew SD, Harrison KJ, Taylor SA, Thomas B, McDonald TJ, Ainsworth PJ, Mulligan LM.

Oncogene. 2005 Feb 3;24(6):1091-7.

PMID:
15592530
13.

Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway.

Andrew SD, Capes-Davis A, Delhanty PJ, Marsh DJ, Mulligan LM, Robinson BG.

Gene. 2002 Sep 18;298(1):9-19.

PMID:
12406571
14.

Sp1 and Sp3 transactivate the RET proto-oncogene promoter.

Andrew SD, Delhanty PJ, Mulligan LM, Robinson BG.

Gene. 2000 Oct 3;256(1-2):283-91.

PMID:
11054558
15.

Glucocorticoids differentially inhibit expression of the RET proto-oncogene.

Capes-Davis A, Andrew SD, Hyland VJ, Twigg S, Learoyd DL, Dwight T, Marsh DJ, Robinson BG.

Gene Expr. 1999;8(5-6):311-26.

16.

Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma.

Marsh DJ, Andrew SD, Learoyd DL, Pojer R, Eng C, Robinson BG.

Hum Mutat. 1998;Suppl 1:S3-4. No abstract available.

PMID:
9452023
17.

Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.

Gimm O, Marsh DJ, Andrew SD, Frilling A, Dahia PL, Mulligan LM, Zajac JD, Robinson BG, Eng C.

J Clin Endocrinol Metab. 1997 Nov;82(11):3902-4.

PMID:
9360560
18.

Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.

Marsh DJ, Zheng Z, Arnold A, Andrew SD, Learoyd D, Frilling A, Komminoth P, Neumann HP, Ponder BA, Rollins BJ, Shapiro GI, Robinson BG, Mulligan LM, Eng C.

J Clin Endocrinol Metab. 1997 Sep;82(9):3025-8.

PMID:
9284737
19.

Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma.

Marsh DJ, Andrew SD, Eng C, Learoyd DL, Capes AG, Pojer R, Richardson AL, Houghton C, Mulligan LM, Ponder BA, Robinson BG.

Cancer Res. 1996 Mar 15;56(6):1241-3.

20.

Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.

Marsh DJ, Learoyd DL, Andrew SD, Krishnan L, Pojer R, Richardson AL, Delbridge L, Eng C, Robinson BG.

Clin Endocrinol (Oxf). 1996 Mar;44(3):249-57.

PMID:
8729519
21.

The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.

Marsh DJ, McDowall D, Hyland VJ, Andrew SD, Schnitzler M, Gaskin EL, Nevell DF, Diamond T, Delbridge L, Clifton-Bligh P, Robinson BG.

Clin Endocrinol (Oxf). 1996 Feb;44(2):213-20.

PMID:
8849577

Supplemental Content

Loading ...
Support Center